Author: Newsdesk

Posted on

IBTA Investors Have Opportunity to Lead Ibotta, Inc. Securities Lawsuit First Filed by the Firm

PR Newswire


NEW YORK
, April 19, 2025 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Ibotta, Inc. (NYSE: IBTA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Ibotta’s April 18, 2024 initial public offering (the “IPO”). If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025.

So What: If you purchased Ibotta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Ibotta class action, go to https://rosenlegal.com/submit-form/?case_id=36526 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose the risks concerning Ibotta’s contract with The Kroger Co. (“Kroger”). Kroger’s contract was at-will, and Ibotta failed to warn investors that a large client could cancel their contract with Ibotta without warning. Despite providing a detailed explanation of the terms of Ibotta’s contract with another large customer, there was not a single warning of the at-will nature of Kroger’s contract. Rather than disclosing the very real risk of a major client walking away at any time, Ibotta provided boilerplate warnings concerning the importance of maintaining ongoing relationships with their clients. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Ibotta action, go to https://rosenlegal.com/submit-form/?case_id=36526 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ibta-investors-have-opportunity-to-lead-ibotta-inc-securities-lawsuit-first-filed-by-the-firm-302432577.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

MONDAY INVESTOR DEADLINE: Constellation Brands, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – STZ

PR Newswire


SAN DIEGO
, April 19, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Constellation Brands, Inc. (NYSE: STZ) securities between April 11, 2024 and January 8, 2025, both dates inclusive (the “Class Period”), have until this upcoming Monday, April 21, 2025 to seek appointment as lead plaintiff of the Constellation Brands class action lawsuit.  Captioned Meza v. Constellation Brands, Inc., No. 25-cv-06107 (W.D.N.Y.), the Constellation Brands class action lawsuit charges Constellation Brands as well as certain of Constellation Brands’ top executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Constellation Brands class action lawsuit, please provide your information here:


https://www.rgrdlaw.com/cases-constellation-brands-inc-class-action-lawsuit-stz.html
 

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: Constellation Brands produces, imports, markets, and sells beer, wine, and spirits.

The Constellation Brands class action lawsuit alleges that defendants throughout the Class Period: (i) created the false impression that they possessed reliable information pertaining to Constellation Brands’ Wine and Spirits business; (ii) failed to improve mix, inventory, and sales execution; and (iii) failed to disclose that investments made in media spend and price promotions as well as adjustments in sales capabilities to support distributor partners had not been as effective as they claimed.

The Constellation Brands class action lawsuit further alleges that on January 10, 2025, Constellation Brands announced its third quarter fiscal year 2025 results, revealing a significant miss on sales performance in the Beer segment and an even steeper miss for the Wine and Spirits segment.  On this news, the price of Constellation Brands’ stock fell.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Constellation Brands securities during the Class Period to seek appointment as lead plaintiff in the Constellation Brands class action lawsuit.  A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.  A lead plaintiff acts on behalf of all other class members in directing the Constellation Brands class action lawsuit.  The lead plaintiff can select a law firm of its choice to litigate the Constellation Brands class action lawsuit.  An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Constellation Brands class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud cases.  Our Firm has been #1 in the ISS Securities Class Action Services rankings for six out of the last ten years for securing the most monetary relief for investors.  We recovered $6.6 billion for investors in securities-related class action cases – over $2.2 billion more than any other law firm in the last four years.  With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig.  Please visit the following page for more information:


https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 

Services may be performed by attorneys in any of our offices. 

Contact:

            Robbins Geller Rudman & Dowd LLP

            J.C. Sanchez, Jennifer N. Caringal

            655 W. Broadway, Suite 1900, San Diego, CA 92101

            800-449-4900

            [email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/monday-investor-deadline-constellation-brands-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit—stz-302429825.html

SOURCE Robbins Geller Rudman & Dowd LLP

Posted on

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

PR Newswire


NEW YORK
, April 19, 2025 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important June 3, 2025 lead plaintiff deadline.

So what: If you purchased Viatris securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Viatris class action, go to https://rosenlegal.com/submit-form/?case_id=36783 call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, during the Class Period, defendants provided investors with material information concerning the failed inspection of Viatris’ Indore, India facility. Defendants’ statements, albeit made months after the initial inspection and defendants’ initiation of remediation efforts included, among other things, the disclosure of the FDA’s issuance of a warning letter and import alert which would prevent Viatris from shipping eleven products from the Indore facility, though four of such were exempt from the limitations (the “Warning Letter”). Defendants routinely referred to the impact of the Warning Letter as a mere “minor headwind” for Viatris.

Further, defendants provided these disclosures to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state impact of the Warning Letter on Viatris’ financials. Notably, defendants did not disclose precisely when the inspection occurred, how long the remediation efforts had been implemented, or the financial impact of the existing and continued remediation efforts. Defendants further notably failed to disclose which products were subject to the FDA Warning Letter, which products were subject to exemptions, and the significance of the restricted products with respect to Viatris’ existing financials and future projections, and for which Viatris believed it would obtain exemptions. Such statements, absent these material facts, caused Plaintiff and other shareholders to purchase Viatris’ securities at artificially inflated prices. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Viatris class action, go to https://rosenlegal.com/submit-form/?case_id=36783 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vtrs-investors-have-opportunity-to-lead-viatris-inc-securities-fraud-lawsuit-302432723.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

TFII Investors Have Opportunity to Lead TFI International Inc. Securities Fraud Lawsuit

PR Newswire


NEW YORK
, April 19, 2025 /PRNewswire/ — 

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TFI International Inc. (NYSE: TFII) between April 26, 2024 and February 19, 2025, both dates inclusive (the “Class Period”), of the important May 13, 2025 lead plaintiff deadline.

So what: If you purchased TFI International securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the TFI International class action, go to https://rosenlegal.com/submit-form/?case_id=36984 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 13, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) TFI was losing small and medium business customers; (2) as a result, TFI’s TForce Freight revenue was declining; (3) TFI was experiencing difficulties managing its costs; (4) as a result of the foregoing, the profitability of its largest business segment was declining; and (5) as a result of the foregoing, defendants’ positive statements about TFI’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the TFI International class action, go to https://rosenlegal.com/submit-form/?case_id=36984 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tfii-investors-have-opportunity-to-lead-tfi-international-inc-securities-fraud-lawsuit-302432746.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

BKKT Investors Have Opportunity to Lead Bakkt Holdings, Inc. Securities Fraud Lawsuit

PR Newswire


NEW YORK
, April 19, 2025 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bakkt Holdings, Inc. (NYSE: BKKT) between March 25, 2024 and March 17, 2025, both dates inclusive (the “Class Period”), of the important June 2, 2025 lead plaintiff deadline

So what: If you purchased Bakkt securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Bakkt class action, go to https://rosenlegal.com/submit-form/?case_id=5546 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 2, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) misrepresented the stability and/or diversity of its crypto services revenue; (2) failed to disclose Bakkt’s Crypto services revenue was substantially dependent on a single contract with Webull; (3) misrepresented its ability to maintain key client relationships; and (4) as a result of the foregoing, defendants’ positive statements about Bakkt’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Bakkt class action, go to https://rosenlegal.com/submit-form/?case_id=5546 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bkkt-investors-have-opportunity-to-lead-bakkt-holdings-inc-securities-fraud-lawsuit-302432700.html

SOURCE THE ROSEN LAW FIRM, P. A.

Posted on

TBBK INVESTOR NEWS: The Bancorp, Inc. Investors may be able to Recover Losses in Class Action Lawsuit — Contact BFA Law before May 16 Deadline (NASDAQ:TBBK)

NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against The Bancorp, Inc. (NASDAQ: TBBK) and certain of the Company’s senior executives for potential violations of the federal securities laws.

If you invested in Bancorp, you are encouraged to obtain additional information by visiting

https://www.bfalaw.com/cases-investigations/the-bancorp-inc
.

Investors have until May 16, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Bancorp stock.   The case is pending in the U.S. District Court for the District of Delaware and is captioned Linden v. The Bancorp, Inc., et al., No. 25-cv-00326.

Why was Bancorp Sued for Securities Fraud?

Bancorp is a financial holding company that engages in institutional banking, commercial real estate bridge lending, small business lending and commercial fleet leasing. Its commercial real estate bridge loans (“REBLs”) are primarily collateralized by apartment buildings.

The complaint alleges that Bancorp misrepresented the significant risk of default or loss on its REBL loan portfolio and that its credit loss methodology was insufficient to account for the allowance of credit losses. As alleged, Bancorp also misrepresented the effectiveness of its internal controls over financial reporting as they contained at least one material weakness.

The Stock Declines as the Truth is Revealed

On March 21, 2024, Culper Research issued a report stating that Bancorp had misrepresented the significant risks of default and/or loss on certain Bancorp REBL loans. According to Culper Research, Bancorp’s REBL loan portfolio is filled with apartments which are “quite literally, crumbling,” with high vacancies and multiple condemnations and that its portfolio consisted of loans to unsophisticated borrowers who were coaxed by “get rich quick” promises. This news caused the price of Bancorp stock to decline over 10%, from $36.04 per share on March 21, 2024, to $32.12 per share on March 21, 2024.

On October 24, 2024, Bancorp announced its Q3 2024 results, disclosing net income of only $51.5 million due to “a new CECL [current expected credit losses methodology] factor” to REBL loans which increased credit losses and resulted in a post-tax reduction in net income of $1.5 million. This news caused the price of Bancorp stock to decline over 14%, from $54.96 per share on October 24, 2025, to $47.01 per share on October 25, 2025.

Finally, on March 4, 2025, Bancorp disclosed that it had “inappropriately filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024” and informed investors that its financial statements from 2022 to 2024 as reflected in that Annual Report should no longer be relied upon. Bancorp revealed that its auditors did not approve the use of its audit opinions for those years. This news caused the price of Bancorp stock to decline 4.4%, from $53.59 per share on March 4, 2025, to $51.25 per share on March 5, 2025.

Click here if you suffered losses:

https://www.bfalaw.com/cases-investigations/the-bancorp-inc

.

What Can You Do?

If you invested in Bancorp you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases-investigations/the-bancorp-inc

Or contact:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases-investigations/the-bancorp-inc

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

ATKR INVESTOR NEWS: Atkore Inc. Investors may be able to Recover Losses in Class Action Lawsuit — Contact BFA Law before April 23 Deadline (NYSE:ATKR)

NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Atkore Inc. (NYSE: ATKR) and certain of the Company’s senior executives for potential violations of the federal securities laws.

If you invested in Atkore, you are encouraged to obtain additional information by visiting

https://www.bfalaw.com/cases-investigations/atkore-inc
.

Investors have until April 23, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Atkore stock.   The case is pending in the U.S. District Court for the Northern District of Illinois and is captioned Westchester Putnam Counties Heavy & Highway Laborers Local 60 Benefits Fund v. Atkore Inc., et al., No. 25-cv-01851.

Why was Atkore Sued for Securities Fraud?

Atkore manufactures electrical, safety, and infrastructure products including polyvinyl chloride water and electrical conduit pipes (“PVC Pipe”). During the COVID-19 pandemic, shipping costs rose dramatically, leaving foreign PVC Pipe manufacturers unable to profitably sell PVC Pipe in the U.S. As shipping prices returned to normal when the pandemic subsided in 2022, foreign PVC Pipe manufacturers gradually returned to the U.S. market. Shortly thereafter, in late 2022, the price of PVC Pipe began to decline.

As alleged, Atkore repeatedly misrepresented that post-pandemic PVC Pipe price declines were the result of “pricing normalization” that reflected “competitive dynamics” and assured investors that the Company would continue to successfully compete in the post-COVID-19 market.

On July 24, 2024, an activist investor named ManBear published a report titled “Pipe Price Fixing” which accused Atkore and three of its competitors of using the commodity pricing service OPIS to coordinate pricing actions and fix the price of PVC Pipe.

In truth, it is alleged that Atkore engaged in an anticompetitive price-fixing scheme that artificially inflated the price of PVC Pipes.

The Stock Declines as the Truth is Revealed

On February 4, 2025, Atkore announced disappointing earnings and reduced guidance, disclosing that the “plastic pipe and conduit product category declined mid-single digits during the quarter” compared to “high single digits in the prior year,” and largely attributed the guidance reduction to Atkore’s PVC Pipe business, stating, “roughly $75 million or 3/4 [of the guidance reduction] is on the PVC side.” This news caused the price of Atkore stock to decline nearly 20%, from $79.72 per share on February 3, 2025 to $64.13 per share on February 4, 2025.

On February 14, 2025, Atkore disclosed that it received a grand jury subpoena from the U.S. Department of Justice Antitrust Division seeking the “production of documents relating to the pricing of the Company’s PVC pipe and conduit products.”

Click here if you suffered losses:

https://www.bfalaw.com/cases-investigations/atkore-inc

.

What Can You Do?

If you invested in Atkore you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases-investigations/atkore-inc

Or contact:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases-investigations/atkore-inc

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

VTRS INVESTOR NEWS: Viatris Inc. Investors may be able to Recover Losses in Class Action Lawsuit — Contact BFA Law before June 3 Deadline (NASDAQ:VTRS)

NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company’s senior executives for potential violations of the federal securities laws.

If you invested in Viatris, you are encouraged to obtain additional information by visiting

https://www.bfalaw.com/cases-investigations/viatris-inc
.

Investors have until June 3, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Viatris securities.   The case is pending in the U.S. District Court for the Western District of Pennsylvania and is captioned Quinn v. Viatris Inc., et al., No. 25-cv-466.

Why was Viatris Sued for Securities Fraud?

Viatris is a global healthcare company that supplies medicines to about 1 billion patients across more than 165 countries and territories. The complaint alleges that Viatris stated its facilities were in “good operating condition,” were “suitable for their intended purposes,” and that the Company was “committed to maintaining the highest quality manufacturing standards.”

However, on December 23, 2024, the Company revealed that the U.S. Food and Drug Administration had issued a Warning Letter following a failed inspection at the Company’s Indore, India, facility. Still, Viatris downplayed the situation, describing it as a “little bit of headwind” and spoke about “active discussions with the FDA” to get additional products produced at the facility exempted from the FDA’s Import Alert.

In truth, the ramifications of the failed FDA inspection resulted in a significant headwind to the Company’s financial results as it prevented the Company from manufacturing and distributing key products, including Lenalidomide.

The Stock Declines as the Truth is Revealed

On February 27, 2025, the Company released its Q4 2024 results and provided 2025 guidance. The Company revealed that the “negative impact” of the Indore facility’s failed inspection would lower 2025 revenue by “approximately $500 million” and 2025 earnings from operations by “approximately $385 million.” The Company further disclosed that the failed inspection at its Indore facility prevented it from identifying alternative supply options for Lenalidomide and from obtaining further product exemptions from the FDA. On this news, the price of Viatris stock declined roughly 15% during the trading day, from a closing price of $11.24 per share on February 26, 2025, to $9.53 per share on February 27, 2025.

Click here if you suffered losses:

https://www.bfalaw.com/cases-investigations/viatris-inc

.

What Can You Do?

If you invested in Viatris you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases-investigations/viatris-inc

Or contact:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases-investigations/viatris-inc

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

RC INVESTOR NEWS: Ready Capital Investors may be able to Recover Losses in Class Action Lawsuit — Contact BFA Law before May 5 Deadline (NYSE:RC)

NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Ready Capital Corporation (NYSE: RC) and certain of the Company’s senior executives for potential violations of the federal securities laws.

If you invested in Ready Capital, you are encouraged to obtain additional information by visiting

https://www.bfalaw.com/cases-investigations/ready-capital-corporation
.

Investors have until May 5, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Ready Capital stock. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Quinn v. Ready Capital Corporation, et al., No. 25-cv- 01883.

Why was Ready Capital Sued for Securities Fraud?

Ready Capital is a real estate finance company which originates, acquires, finances and services lower-to-middle-market (LLM) commercial real estate (CRE) loans, small business administration loans, residential mortgage loans, and other real estate-related investments.

As alleged, Ready Capital misrepresented the credit performance of its loans, stating that its “CRE portfolio is showing stabilizing credit metrics” and that it was “well positioned to capitalize on the tailwinds in the CRE market.” In reality, Ready Capital’s CRE portfolio was plagued by non-performing loans and its CRE portfolio had not stabilized.

The Stock Declines as the Truth is Revealed

On March 3, 2025, Ready Capital announced financial results for 4Q 24, disclosing that it would recognize a $382 million charge, which included $284 million in combined Current Expected Credit Losses (CECL) and valuation allowances on its nonperforming loans. Ready Capital also announced it would be reducing its dividend to $0.125 per share.

This news caused the price of Ready Capital stock to decline almost 27%, from $6.93 per share at close on February 28, 2025, to $5.07 per share at close on March 3, 2025.

Click here if you suffered losses:

https://www.bfalaw.com/cases-investigations/ready-capital-corporation

.

What Can You Do?

If you invested in Ready Capital you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases-investigations/ready-capital-corporation

Or contact:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases-investigations/ready-capital-corporation

Attorney advertising. Past results do not guarantee future outcomes.



Posted on

BBAI INVESTOR NEWS: BigBear.ai Holdings, Inc. Investors may be able to Recover Losses in Class Action Lawsuit — Contact BFA Law before June 10 Deadline (NYSE:BBAI)

NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE: BBAI) and certain of the Company’s senior executives for potential violations of the federal securities laws.

If you invested in BigBear.ai, you are encouraged to obtain additional information by visiting

https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc
.

Investors have until June 10, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased BigBear.ai securities.   The case is pending in the U.S. District Court for the Eastern District of Virginia and is captioned Priewe v. BigBear.ai Holdings, Inc., et al., No. 25-cv-00623.

Why was BigBear.ai Sued for Securities Fraud?

BigBear.ai is an AI-driven technology solutions company that helps organizations operationalize AI by analyzing complex data and providing actionable insights in areas of national security, supply chain management, and digital identity and biometrics solutions. 

BigBear.ai went public via a special purpose acquisition company (“SPAC”) transaction, completing merging first with GigCapital4 Merger Sub Corporation, and subsequently with GigCapital4, Inc. Upon completion of the merger, BigBear.ai issued $200 million of unsecured convertible notes with a maturity date of December 15, 2026. During the relevant period, BigBear.ai improperly accounted for the 2026 Convertible Notes, causing it to misstate various items in several of the Company’s previously issued financial statements.

The Stock Declines as the Truth is Revealed

On March 18, 2025, BigBear.ai delayed the filing of its 2024 10K, disclosing that certain of the Company’s financial statements since fiscal year 2021 should no longer be relied upon and would be restated. On this news, the price of BigBear.ai stock declined roughly 15%, from a closing price of $3.49 per share on March 17, 2025, to $2.97 per share on March 18, 2025.

Then, on March 25, 2025, after market, BigBear filed its 2024 10-K restating its consolidated financial statements “to reflect the issuance of the 2026 Notes Conversion Option at fair value as of December 7, 2021 and the subsequent remeasurement to fair value at each reporting date.” The 2024 10-K also disclosed that the Company had identified a material weakness in its internal control over financial reporting. On this news, the price of BigBear.ai stock declined roughly 9%, from a closing price of $3.51 per share on March 25, 2025, to $3.19 per share on March 26, 2025.

Click here if you suffered losses:

https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc

.

What Can You Do?

If you invested in BigBear.ai you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc

Or contact:
Ross Shikowitz
[email protected]
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc

Attorney advertising. Past results do not guarantee future outcomes.